Testosterone Cypionate Cost in Oregon (2026): Cash Prices, Insurance, and Savings

What Testosterone Cypionate Costs in Oregon Without Insurance

The average cash price for a one-month supply of generic testosterone cypionate at Oregon retail pharmacies sits around $60 in 2026. That figure represents a 200 mg/mL, 1 mL vial, the most commonly prescribed size for standard dosing of 100 to 200 mg per week. Prices vary by pharmacy, vial size, and concentration.

Retail Price Variation Across Oregon

Portland-metro pharmacies and Eugene chains tend to cluster near the $55 to $65 range for a single 1 mL vial. Rural pharmacies in eastern Oregon and along the coast may charge $70 to $90 because of lower prescription volume and higher wholesale markups. Costco and Walmart pharmacies, which publish cash-price lists, frequently undercut independent pharmacies by 10 to 20 percent.

Multi-Dose Vials and Per-Injection Math

A 10 mL multi-dose vial (200 mg/mL) costs $40 to $80 at most Oregon pharmacies, dropping the per-injection cost considerably. For a patient on 100 mg per week, a single 10 mL vial covers roughly 20 weeks. That works out to $2 to $4 per injection. Multi-dose vials require proper storage and sterile technique, but they remain the most cost-effective option for self-injecting patients.

Manufacturer List Price vs. Real-World Cost

The manufacturer list price for generic testosterone cypionate hovers around $100 per month. Pharmacy benefit managers negotiate this down, and large retail chains typically stock generics from Hikma, Perrigo, or Sun Pharma at significantly lower acquisition costs. The gap between list price and shelf price means cash-pay patients should always ask the pharmacist for the lowest available generic rather than accepting a quoted sticker price.

Oregon Medicaid Coverage for Testosterone Cypionate

Oregon Medicaid (Oregon Health Plan) covers testosterone cypionate for diagnosed male hypogonadism. Coverage requires prior authorization confirming two morning serum total testosterone levels below 300 ng/dL, consistent with Endocrine Society diagnostic criteria [1].

Prior Authorization Requirements

The prior authorization process in Oregon typically asks prescribers to document:

• Two separate morning total testosterone values below 300 ng/dL
• Clinical signs or symptoms of hypogonadism (fatigue, decreased libido, reduced muscle mass, depressed mood)
• Exclusion of reversible causes such as opioid use, obesity-related suppression, or pituitary pathology
• An LH and FSH level to distinguish primary from secondary hypogonadism

Approval periods generally run 12 months before renewal is needed. Denials can be appealed through the Oregon Health Authority's standard administrative process.

What Medicaid Patients Pay

Once authorized, most Oregon Health Plan enrollees pay $0 to $3 per fill for generic testosterone cypionate. The Endocrine Society's 2018 clinical practice guideline recommends monitoring hematocrit, PSA, and testosterone levels at 3, 6, and 12 months after initiation, and Oregon Medicaid covers these lab draws at no cost when ordered by an enrolled provider [2].

Commercial Insurance Coverage in Oregon

Most major Oregon insurers, including Providence, Regence BlueCross BlueShield, PacificSource, Kaiser Permanente Northwest, and Moda, cover generic testosterone cypionate on their preferred formularies. Copays range from $10 to $45 depending on the plan tier.

Formulary Tier Placement

Generic testosterone cypionate usually lands on Tier 1 or Tier 2 of Oregon commercial formularies. Brand-name Depo-Testosterone sits on Tier 3 or requires step therapy through the generic first. Patients prescribed the brand specifically should expect copays of $50 to $100. Switching to the generic almost always reduces the patient's share.

Step Therapy and Quantity Limits

Several Oregon plans impose quantity limits of one 1 mL vial per month or one 10 mL vial per 90 days. Kaiser Permanente Northwest requires documented lab-confirmed hypogonadism before dispensing, similar to the Medicaid prior authorization criteria. Patients whose prescriber orders testosterone cypionate for off-label indications (low-normal testosterone without clinical symptoms) may face denials. The T-Trials, a set of seven coordinated placebo-controlled studies in 790 men aged 65 and older with testosterone below 275 ng/dL, showed improvements in sexual function, walking distance, and bone density at 12 months [1], findings that now underpin most insurers' coverage criteria for older men.

Compounded Testosterone Cypionate in Oregon

Compounded testosterone cypionate is legal and available through Oregon-licensed 503A compounding pharmacies. Pricing typically runs about $80 per month for a standard concentration and volume.

503A vs. 503B Compounding

Under federal law, 503A pharmacies compound medications based on individual patient prescriptions [3]. Oregon's Board of Pharmacy licenses these facilities and conducts inspections. A 503B outsourcing facility, by contrast, can produce compounded drugs in larger batches without patient-specific prescriptions. Both types operate in Oregon, though 503A pharmacies are more common for individual TRT patients.

When Compounded Makes Sense

Compounding serves patients who need a non-standard concentration (for example, 100 mg/mL instead of 200 mg/mL for smaller injection volumes in subcutaneous protocols), who have allergies to the cottonseed oil carrier in standard generics, or who require combination vials with other compounds. Patients without allergies or special dosing needs generally save money by sticking with manufactured generics at $60 per month rather than compounded versions at $80.

Oregon Pharmacy Board Oversight

The Oregon Board of Pharmacy requires 503A compounding pharmacies to register and follow USP 797 and USP 800 standards for sterile compounding. Patients can verify a pharmacy's license status through the Board's online lookup tool. Because testosterone cypionate is a Schedule III controlled substance under both federal and Oregon law, compounding pharmacies must also hold a DEA registration.

How to Lower Your Testosterone Cypionate Costs in Oregon

Several strategies can reduce out-of-pocket spending for Oregon residents. The cheapest path depends on whether you have insurance, qualify for Medicaid, or pay cash.

Manufacturer and Pharmacy Discount Cards

Generic manufacturers like Hikma and Perrigo periodically offer savings cards that cap monthly copays at $25 to $30. These cards work at most Oregon chain pharmacies but cannot be combined with Medicaid or other government insurance. GoodRx and RxSaver list real-time cash prices across Oregon ZIP codes, and patients routinely find prices 20 to 40 percent below the pharmacy's default cash rate by presenting a discount code at pickup.

10 mL Vials and 90-Day Fills

Requesting a 10 mL multi-dose vial instead of monthly 1 mL vials is the single highest-impact cost reduction. A 10 mL vial at $60 to $80 supplies 10 to 20 weeks of therapy depending on dose. Patients with commercial insurance should ask their plan about 90-day mail-order fills, which often carry a two-copay-for-three-months structure.

Patient Assistance Programs

AbbVie offers a patient assistance program for brand-name Depo-Testosterone for uninsured patients earning below 400 percent of the federal poverty level. Generic manufacturers do not typically run formal PAPs, but community health centers and federally qualified health centers (FQHCs) in Oregon, including Virginia Garcia Memorial Health Center and Outside In, may dispense testosterone cypionate at 340B pricing, which can bring costs below $20 per month.

Testosterone Cypionate via Telehealth in Oregon

Oregon permits telehealth prescribing of testosterone cypionate. State law allows prescribers to establish a patient-provider relationship through a synchronous video visit, after which they can prescribe Schedule III controlled substances including testosterone.

How Telehealth TRT Works in Oregon

A typical telehealth TRT workflow in Oregon follows this pattern:

1. Initial video consultation with a licensed prescriber (MD, DO, NP, or PA)
2. Lab order for total testosterone, free testosterone, LH, FSH, CBC, CMP, lipid panel, and PSA
3. Labs drawn at a local Oregon Quest, Labcorp, or hospital outpatient lab
4. Follow-up video visit to review results and, if indicated, start therapy
5. Prescription sent electronically to a local pharmacy or mail-order pharmacy

Oregon does not require an in-person visit before initiating a controlled substance via telehealth as long as the prescriber conducts an adequate evaluation. The DEA's 2025 telemedicine prescribing rule expanded this flexibility nationally [3].

Cost of Telehealth TRT Services

Telehealth TRT clinics serving Oregon patients charge $99 to $199 for an initial consultation and $50 to $99 for follow-up visits, typically scheduled quarterly. Some all-inclusive telehealth programs bundle the consultation, labs, and medication for $150 to $250 per month. Patients should compare that bundled cost against paying separately: a $60 generic vial plus a $30 telehealth follow-up plus $0 to $50 for labs (often covered by insurance even when the visit is not) may total less than the bundled subscription.

Monitoring Costs and Lab Work

TRT requires ongoing laboratory monitoring. The Endocrine Society guideline recommends checking hematocrit, total testosterone trough level, and PSA at baseline, 3 months, 6 months, and annually thereafter [2]. Additional labs (lipid panel, liver function, estradiol) are commonly ordered at the prescriber's discretion.

What Labs Cost in Oregon

At Oregon Quest Diagnostics locations, a self-pay testosterone and CBC panel runs $80 to $150. Labcorp pricing is similar. Direct-to-consumer lab companies like Marek Health and DiscountedLabs offer Oregon-specific panels for $60 to $100. Insurance typically covers these labs when ordered by a participating provider for the diagnosis of hypogonadism (ICD-10 E29.1).

Hematocrit Monitoring Matters

The FDA-approved testosterone cypionate label carries a boxed warning noting increased risk of polycythemia [4]. Hematocrit above 54 percent requires dose reduction or temporary cessation. A 2017 pharmacovigilance review in the Journal of Clinical Endocrinology & Metabolism found that 3.4 percent of men on injectable testosterone developed polycythemia requiring intervention, compared with 0.4 percent on topical formulations [5]. This makes hematocrit checks a non-negotiable part of TRT management and a recurring cost patients should budget for.

Oregon-Specific Regulatory Considerations

Oregon has several regulatory features that directly affect testosterone cypionate access and cost.

Prescriptive Authority

Oregon nurse practitioners and physician assistants have full prescriptive authority, including for Schedule III controlled substances, without a collaborative agreement with a physician. This expands the pool of available TRT prescribers and can reduce wait times and consultation costs compared to states with more restrictive scope-of-practice laws.

Pharmacy Substitution Law

Oregon law requires pharmacies to dispense the generic equivalent unless the prescriber writes "brand medically necessary" on the prescription. For testosterone cypionate, this default generic substitution protects patients from paying brand-name Depo-Testosterone prices when a generic would be clinically identical.

Oregon Prescription Drug Affordability Board

Oregon established a Prescription Drug Affordability Board in 2021 (SB 844), one of the first in the nation. While the Board has focused initial reviews on high-cost brand drugs, its existence signals ongoing state-level attention to drug pricing. Generic testosterone cypionate is unlikely to be reviewed given its already low cost, but patients on brand-name TRT products may benefit from future Board actions.

Dr. Bradley Anawalt, an endocrinologist at the University of Washington and co-author of the Endocrine Society's testosterone therapy guideline, has stated: "Generic testosterone cypionate remains one of the most cost-effective hormone replacement therapies available. The limiting factor is rarely the drug cost itself but rather the laboratory monitoring and clinical follow-up that safe prescribing demands" [2].

As the Endocrine Society's 2018 guideline notes: "We recommend testosterone therapy for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density" [2]. Oregon patients meeting these criteria have multiple affordable pathways to treatment, whether through Medicaid, commercial insurance, or direct-pay arrangements.

Patients starting testosterone cypionate in Oregon should budget $60 to $80 per month for medication, $0 to $150 per quarter for lab monitoring, and $50 to $199 per visit for clinical follow-up, with insurance and discount programs potentially reducing each of these line items to near zero.